Cargando…

Challenges of Integrating Biosimilars Into Clinical Practice

Presenters at JADPRO Live 2019 discussed the chemical and clinical nature of biosimilars, reviewed biosimilar development in oncology, and discussed implementation strategies for biosimilars.

Detalles Bibliográficos
Autores principales:	Jeffers, Kate, May, Megan, Vogel, Wendy H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2020
Materias:	Meeting Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857316/ https://www.ncbi.nlm.nih.gov/pubmed/33598319 http://dx.doi.org/10.6004/jadpro.2020.11.3.6

Ejemplares similares

Practical Considerations for Integrating Biosimilars Into Clinical Practice
por: May, Megan B., et al.
Publicado: (2021)

Current status and considerations on biosimilar in China
por: Wang, Junzhi
Publicado: (2012)

Integromics: challenges in data integration
por: Venkatesh, TV, et al.
Publicado: (2002)

Integrating Biosimilars Into Oncology Practice: Implications for the Advanced Practitioner
por: Campen, Christopher J.
Publicado: (2017)

Antibody biosimilars: Fears or opportunities?: First LabEx MAbImprove industrial workshop, May 28, 2013; Tours, France
por: Guillon-Munos, Audrey, et al.
Publicado: (2014)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
por: Uifălean, Alina, et al.
Publicado: (2018)

Challenges in clinical genomics
por: MacArthur, Daniel G
Publicado: (2012)

Neratinib for Extended Anti-HER2 Therapy in Early Breast Cancer
por: Budd, G. Thomas, et al.
Publicado: (2018)

Challenges in experimental data integration within genome-scale metabolic models
por: Bourguignon, Pierre-Yves, et al.
Publicado: (2010)

Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice
por: Speight, Neal, et al.
Publicado: (2009)

Biosimilars 101: considerations for U.S. oncologists in clinical practice
por: Camacho, Luis H, et al.
Publicado: (2014)

European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice
por: Barbier, Liese, et al.
Publicado: (2020)

Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice
por: Mayden, Kelley D., et al.
Publicado: (2022)

Meeting the challenges of drug discovery: a multidisciplinary re-evaluation of current practices
por: Burley, Stephen K, et al.
Publicado: (2005)

Integrating Best Practices to Improve Outcomes in Relapsed/Refractory Multiple Myeloma
por: Pierre, Amy E., et al.
Publicado: (2020)

Integrating science and clinical practice in the understanding and treatment of mood disorders
por: Akiskal, Hagop
Publicado: (2010)

What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium
por: Ball, Jonathan
Publicado: (2002)

Biosimilars: Current regulatory perspective and challenges
por: Jha, Diwakar, et al.
Publicado: (2013)

Integrating systems biology with clinical research
por: Pepperkok, Rainer, et al.
Publicado: (2008)

Second Annual Integrative Medicine Symposium: Translating Science into Clinical Practice February 20–21, 2004, UCLA Campus, Los Angeles, CA
por: Cooper, Edwin L.
Publicado: (2004)

Towards the integration of genomics, epidemiological and clinical data
por: Solovyev, Victor V, et al.
Publicado: (2011)

The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018)

Oncology Urgent Care Clinics: Understanding Utilization and Best Practices
por: Fleming, Cara, et al.
Publicado: (2022)

The Advanced Practice Role in Clinical Trials: Past, Present, and Future
por: Lewis, Colleen
Publicado: (2022)

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
por: Waller, Cornelius F., et al.
Publicado: (2021)

Advances in circulating tumor cells (ACTC): from basic research to clinical practice
por: Lianidou, Evi S, et al.
Publicado: (2013)

HIV-associated salivary gland disease: a role for BK birus
por: Jeffers, Liesl Kerlyn, et al.
Publicado: (2010)

Current and future roles of biosimilars in oncology practice
por: Konstantinidou, Sofia, et al.
Publicado: (2020)

Regulatory challenges with biosimilars: an update from 20 countries
por: Kang, Hye‐Na, et al.
Publicado: (2020)

Clinical considerations for biosimilar antibodies
por: Mellstedt, Håkan
Publicado: (2013)

Clinical evaluation of an allergen Challenge Theatre(TM)
por: Karsh, Jacob, et al.
Publicado: (2014)

Addressing the Challenges of Aggressive Lymphomas
por: Byar, Katherine L., et al.
Publicado: (2020)

Clinical trial size - the perfect, the practicable and the present: MRC/CRC meeting, 26 March 1987
Publicado: (1988)

Biosimilars
por: Martin, Miguel
Publicado: (2018)

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
por: Reinisch, Walter, et al.
Publicado: (2020)

Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
por: Kapoor, Sanjiv, et al.
Publicado: (2019)

The challenges and hopes of personalized cancer medicine
por: Xian, Wa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5ges2ot6k7d0m10c94ejolbf7h